Work

Abstract P1-18-03: Pertuzumab (P) plus high-dose trastuzumab (H) for the treatment of central nervous system (CNS) progression after radiotherapy (RT) in patients (pts) with HER2-positive metastatic breast cancer (MBC): Primary efficacy analysis results from the phase II PATRICIA study

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs19-p1-18-03

Authors: Nancy U Lin, Priya Kumthekar, Solmaz Sahebjam, Nuhad Ibrahim, Anita Fung, Anna Cheng, Alan Nicholas, Bei Wang, Mark Pegram

Institutions: Dana-Farber Cancer Institute, Northwestern University, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Stanford Cancer Institute

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3006565222

Cites:

Cited by: 8

Related to: 10